What Is Ablative Surgery and How Does It Work?

Ablative surgery is any procedure that deliberately destroys unwanted tissue, whether a tumor, a misfiring patch of heart muscle, or a nerve transmitting chronic pain, without cutting it out and removing it from the body. Instead of a scalpel and stitches, the surgeon delivers a targeted dose of energy (heat, cold, electrical pulses, or focused sound waves) through a needle, catheter, or external beam to kill cells in place. The dead tissue is then gradually cleared by the body’s own cleanup processes. Because the instruments are small and the damage zone is controlled, most ablative procedures qualify as minimally invasive, often requiring only a tiny skin puncture rather than an open incision.

How Thermal Ablation Works

The most widely used ablative techniques rely on extreme temperatures. Radiofrequency ablation (RFA) passes an alternating electrical current through a needle-like electrode inserted into the target tissue. The current agitates ions in the surrounding cells, generating frictional heat that raises local temperatures above about 60 °C. At that threshold, proteins denature and cells die through a process called coagulative necrosis, in which the tissue architecture stays intact for days while inflammatory cells arrive to clean up the debris.¹ The result is a roughly spherical or elliptical zone of dead tissue surrounding the electrode tip.

Microwave ablation (MWA) works on a related principle but uses electromagnetic waves instead of electrical current. Because microwaves heat tissue directly rather than relying on ionic agitation, the temperature climbs faster and reaches higher peaks. In laboratory comparisons using calf liver, microwaves heated tissue roughly four times faster than radiofrequency energy at the same distance from the probe, and the heated zone extended about 5 mm deeper.² In a randomized trial treating liver malignancies, microwave ablation zones averaged about 37 cm³ compared with roughly 28 cm³ for radiofrequency zones.³ That speed and volume advantage matters when treating larger tumors or tumors near major blood vessels, which act as heat sinks that carry warmth away from the ablation zone.

Cryoablation flips the temperature dial in the other direction. A cryoprobe circulates a compressed gas (typically argon) that rapidly expands at its tip, dropping the temperature well below freezing. Ice crystals form inside cells, rupturing membranes. As the tissue thaws, blood flow returns to damaged vessels and triggers further cell death from clotting and oxygen deprivation.⁴ One practical advantage of cryoablation is that the growing ice ball shows up clearly on imaging, giving the operator a real-time picture of exactly how far the kill zone extends.

Non-Thermal Approaches

Not every ablation procedure uses temperature. Irreversible electroporation (IRE) delivers very short, high-voltage electrical pulses that punch permanent holes in cell membranes. Cells lose the ability to regulate what flows in and out, and they die. The key distinction is that IRE targets only cell membranes while leaving the structural scaffolding of tissue, including blood vessels and connective tissue, largely intact.⁵ That selectivity makes IRE appealing for tumors that sit close to major blood vessels or bile ducts, where heat-based methods risk damaging vital structures.⁶

Histotripsy is an even newer non-thermal method. It uses focused ultrasound pulses so intense that they create tiny bubble clouds inside tissue. When those bubbles collapse, they mechanically shred cells into a liquid slurry. One version uses microsecond-long pulses to generate dense bubble clouds; another uses millisecond-long pulses with shock fronts that interact with boiling vapor to disintegrate tissue.⁷ Because the destruction is purely mechanical and completely external, there is no needle or probe insertion at all.

Treating Heart Rhythm Disorders

Catheter ablation for atrial fibrillation (AF) is one of the highest-profile uses of ablative surgery. The heart’s abnormal electrical signals in AF often originate in or around the pulmonary veins, the vessels that carry oxygenated blood from the lungs into the left atrium. By threading a catheter through a vein in the groin up into the heart, an electrophysiologist can deliver radiofrequency energy or extreme cold to create a ring of scar tissue around each pulmonary vein, electrically isolating the misfiring cells from the rest of the heart. This strategy, called pulmonary vein isolation, has become the cornerstone treatment for AF, offering better rhythm control and symptom relief than antiarrhythmic drugs in many patients.⁸

Results depend heavily on the type of AF. In one study of pulmonary vein isolation, about 70% of patients with the intermittent form (paroxysmal AF) were free from recurrent episodes at five months, and over 80% had either eliminated their symptoms or experienced significant improvement. Patients with the persistent form fared less well, with only about 22% free from recurrence over the same period.⁹ A large randomized trial later tested whether adding more extensive ablation (targeting complex electrical signals or creating extra lines of scar) on top of pulmonary vein isolation would improve outcomes for persistent AF. It did not: after 18 months, roughly 59% of patients who received pulmonary vein isolation alone were free from recurrence, compared with 49% and 46% in the groups that received additional ablation.¹⁰ Simpler, it turns out, can be better.

Tumor Ablation in Oncology

In cancer treatment, ablation is most commonly used for tumors in the liver, kidney, lung, and bone. Liver tumors, whether primary cancers or metastases from elsewhere, are often treated with RFA or MWA. The operator inserts one or more needle probes through the skin under image guidance, positions the tip inside the tumor, and delivers energy for several minutes. One practical challenge is the “heat sink effect”: blood flowing through nearby vessels cools the tissue and shrinks the ablation zone. In laboratory liver models, monopolar RFA lost about 41% of its ablated volume when a simulated blood vessel was present, while microwave ablation lost only about 22%.¹¹ This is one reason microwave ablation has gained ground for liver lesions near large vessels.

Kidney tumors offer a slightly different trade-off. Cryoablation is a popular choice for small kidney masses (clinical stage T1, roughly up to 7 cm) because it can be performed through a small puncture, causes fewer complications than partial nephrectomy (surgically cutting out the tumor while saving the rest of the kidney), and preserves more kidney function. The catch is that cancer recurrence rates are higher. A systematic review and meta-analysis found that cryoablation was associated with fewer overall complications and better preservation of kidney function compared to partial nephrectomy, but at the cost of poorer long-term tumor control.¹² A more recent meta-analysis comparing cryoablation to robot-assisted partial nephrectomy put numbers on this: cryoablation patients had shorter hospital stays (by about 1.8 days), substantially less blood loss, and fewer overall complications, but the recurrence rate was nearly eight times higher.¹³ For older patients or those with significant health risks that make open surgery dangerous, the gentler recovery of cryoablation may outweigh the higher recurrence risk. For younger, healthier patients, surgical excision remains the more durable option.

Ablation in the Brain

Brain tissue is perhaps the most high-stakes target for ablation, and precision matters immensely. MRI-guided focused ultrasound (MRgFUS) thalamotomy is a completely incisionless procedure used primarily for essential tremor, a condition that causes uncontrollable hand shaking. The patient lies inside an MRI scanner wearing a helmet fitted with over a thousand ultrasound transducers. The beams converge on a small spot in the thalamus (the brain’s sensory relay station), heating that spot enough to destroy the cells responsible for the abnormal tremor signal. Real-time MRI thermometry lets the surgeon watch the temperature rise degree by degree. A landmark randomized trial found that hand-tremor scores dropped from about 18 points at baseline to roughly 10 points at three months after focused ultrasound thalamotomy, compared with virtually no change in a sham-treated group. The improvement held at 12 months.¹⁴

Because essential tremor often affects both hands, there is interest in treating both sides of the brain. A clinical trial of staged bilateral focused ultrasound thalamotomy reported a roughly two-thirds reduction in overall tremor scores at three months, with postural tremor improving by about 81%. Those improvements remained similar at 12 months.¹⁵ The procedure carries real risks, including transient numbness and gait unsteadiness, so patient selection is careful.

For targets deeper in the brain or for conditions like drug-resistant epilepsy and brain tumors, laser interstitial thermal therapy (LITT) offers another minimally invasive route. A thin fiber-optic probe is stereotactically guided through a small drill hole in the skull and into the target. Near-infrared laser light heats and destroys tissue, again under real-time MRI monitoring.¹⁶ LITT has been applied to brain metastases, radiation necrosis, gliomas, and epileptogenic foci with limited corridor-related morbidity and faster recovery than open craniotomy.¹⁷

Pain Management With Ablation

Ablation has a long history in pain medicine. Radiofrequency neurotomy for spinal pain dates back to the early 1970s, when Shealy first applied RF electrodes to the nerves supplying the facet joints. Subsequent refinements by Bogduk and others in the 1980s established percutaneous lumbar medial branch neurotomy, and the field continued to evolve through innovations like pulsed radiofrequency (invented in 1998) and cooled radiofrequency probes.¹⁸ The principle is the same across all variants: interrupt the nerve’s ability to transmit pain signals by heating (or in the case of pulsed RF, modulating) the nerve fiber.

A growing area is the ablation of painful bone metastases, where tumors that have spread to bone cause severe pain that does not always respond well to medication or radiation. A systematic review and meta-analysis of studies using RFA and cryoablation for painful bone metastases found that both methods significantly reduced pain at every follow-up time point. RFA showed the greatest pain reduction at six months, while cryoablation had a larger immediate effect at 24 hours but a somewhat smaller benefit at six months.¹⁹ For patients with limited life expectancy and tumors resistant to other treatments, ablation can provide meaningful relief with a single outpatient session.

Gynecological and Dermatological Uses

Endometrial ablation is one of the most common ablative procedures performed in gynecology. Women with heavy menstrual bleeding who do not wish to have future pregnancies can have the lining of the uterus (the endometrium) destroyed using heat, cold, or electrical energy, avoiding the need for hysterectomy. A network meta-analysis comparing second-generation devices found that bipolar radiofrequency and microwave ablation produced higher rates of amenorrhea (complete cessation of periods) at about 12 months than thermal balloon ablation, though patient satisfaction was broadly similar across techniques.²⁰ A separate meta-analysis confirmed that bipolar radiofrequency endometrial ablation was roughly 2.7 times more likely to achieve amenorrhea at 12 months than thermal balloon ablation, though both improved quality of life.²¹ Many of these procedures can be done in an office setting rather than an operating room.

In dermatology, ablative lasers, primarily CO₂ and erbium lasers, vaporize thin layers of skin to treat wrinkles, scars, and sun damage. The laser creates microscopic columns of thermal injury through the epidermis and into the dermis. The wound-healing response that follows triggers new collagen and elastin production, effectively remodeling the skin from below.²² Fractional ablative lasers refine this by treating only a fraction of the skin surface in each session, leaving islands of intact tissue between the microscopic treatment columns. This speeds healing and reduces the risk of complications like prolonged redness or pigmentation changes.²³

Risks and Complications

Ablation is minimally invasive, but it is not risk-free. Complications fall broadly into two buckets: those related to getting the probe into position (bleeding, infection, puncturing the wrong structure, tumor seeding along the needle tract, or pneumothorax when treating lung or upper abdominal targets) and those caused by the energy itself (thermal damage to structures adjacent to the target, or in the case of radiofrequency ablation, grounding pad burns).²⁴ Thermal injury to non-target organs, such as the bile duct, diaphragm, or bowel wall, is a recognized hazard when ablating liver tumors that happen to sit near those structures.²⁵ In cardiac ablation, rare but serious complications include pulmonary vein stenosis and damage to the esophagus or phrenic nerve, which runs close to the heart.²⁶

Accurate image guidance is the main safeguard against these problems. Most percutaneous ablations are performed under ultrasound, CT, or MRI guidance, and increasingly under hybrid approaches that fuse pre-procedure imaging (like PET/CT scans) with real-time ultrasound to help the operator see both the tumor and the surrounding anatomy at the same time. One study of liver metastasis ablation using real-time fusion of ultrasound with prior PET/CT images found the approach was feasible, safe, and effective, and that adding contrast enhancement improved accuracy and shortened procedure times.²⁷

Why Ablation Sometimes Helps the Immune System

One of the more surprising findings in ablation research is that destroying a tumor can sometimes prime the immune system to attack cancer cells elsewhere in the body, a phenomenon called the abscopal effect. When tumor cells are killed rapidly, they release their internal contents, including proteins that the immune system can recognize as foreign. In patients with lung cancer treated with microwave ablation, researchers observed a significant spike in key immune-signaling molecules (such as certain interleukins and interferon-gamma) within 24 hours after the procedure, along with shifts in immune cell populations consistent with an activated antitumor response.²⁸

The method of destruction seems to matter for how much immune activation occurs. Non-thermal techniques may have an edge here. Histotripsy, the bubble-cloud-based ultrasound method, was shown to release tumor antigens with preserved immunogenicity, triggering molecular signals associated with a type of cell death that the immune system recognizes as dangerous.²⁹ Similarly, pulsed electric field ablation outperformed conventional radiofrequency ablation in a mouse breast cancer model, recruiting more dendritic cells, natural killer cells, and antigen-specific T cells to the tumor site while reducing the immunosuppressive cells that tumors use to hide from the immune system.³⁰ The idea of combining ablation with immunotherapy drugs to amplify this effect is one of the most actively explored frontiers in interventional oncology.

Pulsed Field Ablation in Cardiology

Pulsed field ablation (PFA) represents the newest energy modality to reach widespread clinical use, and its arrival has been most felt in cardiology. PFA applies the same irreversible electroporation principle described earlier, but through cardiac catheters. Because heart muscle cells are more sensitive to electrical-field-induced membrane disruption than the cells of surrounding structures like nerves and blood vessels, PFA can destroy the arrhythmia-causing tissue while sparing adjacent anatomy. Preclinical work in a chronic porcine model demonstrated that PFA-based pulmonary vein isolation was both safe and effective, with confirmed sparing of nearby nerves and venous tissue.³¹ This tissue selectivity could reduce some of the rarest but most feared complications of traditional thermal cardiac ablation, including esophageal injury and phrenic nerve paralysis.²⁶

PFA has moved quickly from animal models to approved clinical use in multiple countries. Early human results have been promising enough that many electrophysiology labs now offer PFA alongside or instead of radiofrequency and cryoballoon ablation for AF. The technology is still young, though, and long-term recurrence data and head-to-head randomized comparisons with established methods are still being gathered. For now, PFA’s main selling point is its safety profile rather than a proven superiority in rhythm outcomes.

When Ablation Replaces Open Surgery

A recurring theme across specialties is that ablation trades a small increase in recurrence risk for a substantially easier recovery. A multicenter study comparing ultrasound-guided microwave ablation to open surgery for plasma cell mastitis (a painful inflammatory breast condition) found that ablation patients had significantly shorter hospital stays, shorter procedure times, and less blood loss.³² This pattern echoes what appears in kidney, liver, uterine, and cardiac applications: shorter procedures, less pain, faster discharge, but the underlying tissue is not physically removed and confirmed clear under a microscope the way a surgical specimen would be.

That distinction matters. When a surgeon removes a tumor, a pathologist can examine the margins under a microscope to confirm that no cancer cells remain at the edges. With ablation, the tissue stays in place and gets absorbed over weeks to months, so the operator relies on follow-up imaging rather than a pathology report to confirm complete destruction. Incomplete ablation, where a thin rim of surviving tumor cells persists at the edge of the treatment zone, is the main reason recurrence rates tend to be higher after ablation than after surgical excision. For small tumors that fall well within the ablation zone and a planned margin of normal tissue, the difference is often clinically insignificant. For larger or irregularly shaped tumors, or those in anatomically tricky locations, ablation alone may not be enough, and multidisciplinary teams weigh ablation against surgery, radiation, and systemic therapies on a case-by-case basis.